An Amino-Terminal Domain of Mxil Mediates Anti-Myc Oncogenic Activity and Interacts with a Homolog of the Yeast Transcriptional Repressor SIN3

Total Page:16

File Type:pdf, Size:1020Kb

An Amino-Terminal Domain of Mxil Mediates Anti-Myc Oncogenic Activity and Interacts with a Homolog of the Yeast Transcriptional Repressor SIN3 CORE Metadata, citation and similar papers at core.ac.uk Provided by Elsevier - Publisher Connector Cell, Vol, 80, 777-786, March 10, 1995, Copyright © 1995 by Cell Press An Amino-Terminal Domain of Mxil Mediates Anti-Myc Oncogenic Activity and Interacts with a Homolog of the Yeast Transcriptional Repressor SIN3 Nicole Schreiber-Agus,*t Lynda Chin,*tt Ken Chen,t et al., 1990), and a carboxy-terminal a-helical domain re- Richard Torres, t Govinda Rao,§ Peter Guida,t quired for dimerization with another basic region-helix- Arthur h Skoultchi,§ and Ronald A. DePinhot Ioop-helix-leucine zipper (bHLH-LZ) protein, Max (Black- "rDepartments of Microbiology and Immunology wood and Eisenman, 1991; Prendergast et al., 1991). and of Medicine Many of the biochemical and biological activities of Myc §Department of Cell Biology appear to be highly dependent upon its association with ~Division of Dermatology Max (Blackwood and Eisenman, 1991 ; Prendergast et al., Albert Einstein College of Medicine 1991; Kretzner et al., 1992; Amati et al., 1993a, 1993b). Bronx, New York 10461 In addition to its key role as an obligate partner in transacti- vation-competent Myc-Max complexes, Max may also re- press Myc-responsive genes through the formation of Summary transactivation-inert complexes that are capable of bind- ing the Myc-Max recognition sequence (Blackwood et al., Documented interactions among members of the Myc 1992; Kato et al., 1992; Kretzner et al., 1992; Makela et superfamily support a yin-yang model for the regula- al., 1992; Mukherjee et al., 1992; Prendergast et al., 1992; tion of Myc-responsive genes in which t ransactivation- Ayer et al., 1993; Zervos et al., 1993). These complexes competent Myc-Max heterodimers are opposed by re- include Max-Max homodimers, whose DNA-binding activ- pressive Mxil-Max or Mad-Max complexes. Analysis ity is subject to regulation by casein kinase II phosphoryla- of mouse taxi1 has led to the identification of two mxil tion (Berberich and Cole, 1992), and the recently de- transcript forms possessing open reading frames that scribed heterodimers Mad-Max (Ayer et al., 1993) and differ in their capacity to encode a short amino- Mxil-Max (Zervos et al., 1993). Together, these function- terminal e-helical domain. The presence of this seg- ally interactive and structurally related bHLH-LZ proteins ment dramatically augments the suppressive potential comprise an expanding Myc superfamily. of Mxil and allows for association with a mammalian The biochemical properties of the highly homologous protein that is structurally homologous to the yeast MAD and MXll have led to a model for their regulation of transcriptional repressor SIN3. These findings provide Myc activity in which these two proteins compete with Myc a mechanistic basis for the antagonistic actions of for binding both to Max and to common target sequences Mxil on Myc activity that appears to be mediated in part (Ayer et al., 1993; Zervos et al., 1993). As such, the relative through the recruitment of a putative transcriptional intracellular levels of Mad and Mxil in comparison to those repressor. of Myc influence the transcriptional activation of Myc- responsive genes through a dynamic interchange be- Introduction tween the formation of transactivation-inert (Mad-Max or Mxil-Max) and transactivation-competent (Myc-Max) Members of the myc family of nuclear proto-oncogenes (c-, complexes (Ayer et al., 1993; Zervos et al., 1993). The N-, and L-myc) play central roles in the control of normal opposing relationship between Myc and Mad or Mxil de- growth and development and in genetic pathways linked rives further support from biological studies demonstrating to cellular transformation and apoptotic cell death (Evan that, during the approach of many cell lineages to the ter- and Littlewood, 1993; Morgenbesser and DePinho, 1994). minally differentiated state, MXl and MAD mRNA and pro- Accumulating structural, biochemical, and genetic evi- tein levels increase, while those of c-MYC decrease (Ayer dence affords the view that the function of Myc familyonco- et al., 1993; Ayer and Eisenman, 1993; Zervos et al., 1993; proteins in these diverse processes relates in part to their Larsson et al., 1994; Schreiber-Agus et al., 1994), and that roles as sequence-specific transcription factors (for re- overexpression of MXll and MAD can antagonize myc views see Kato and Dang, 1992; Torres et al., 1992). Myc activity in cellular transformation assays (Lahoz et al., family oncoproteins appear to influence the expression of 1994). The anti-oncogenic activity of Mad and Mxil ac- growth-promoting genes, such as those involved in DNA quires particular significance with the localization of MAD synthesis (Bello-Fernandez et al., 1993) and cell cycle reg- and MXI1 genes to chromosomal loci implicated in the ulation (Jansen-Durr et al., 1993), in a positive manner. genesis of several human cancers (Edelhoff et al., 1994; Myc may also play a repressive role in the regulation of M. F. Seldin and R. A. D., unpublished data). some genes through interaction with an initiation factor of Progress on the elucidation of the precise molecular the general transcriptional machinery (Roy et al., 1993). actions of Myc at the level of Myc-responsive gene targets Myc family proteins possess a multifunctional amino- and on the relation of such actions to growth and differenti- terminal domain with transactivation potential (Kato et al., ation has been hampered by the modest transactivation 1990), a region rich in basic amino acid residues responsi- activity of Myc in available transcription reporter assays ble for sequence-specific DNA-binding activity (Blackwell and by the limited repertoire of bona fide myc gene targets. As an alternative strategy to understanding the nature of the actions of Myc and of the functional relationships *The first two authors contributed equallyto this work. among members of the Myc superfamily, we and others Cell 778 have used the rat embryo fibroblast (REF) cooperation two mRNAs through alternative RNA processing (N. S.-A., assay (Land et al., 1983). This highly quantitative biologi- H.-W. Lee, and R. A. D., unpublished data). cal assay takes advantage of a long-recognized property Nucleic acid sequence analysis of the tmxi-SR cDNA of Myc, namely, its ability to cooperate with activated H-RAS clone revealed an ATG-initiated open reading frame (ORF) (Val-12) to effect the malignant transformation of early- capable of encoding a protein of 228 amino acids with a passage REFs. The REF cooperation assay has proven predicted molecular size of 25,977 Da (Mxi-SR in Figure effective in the evaluation of candidate modulators of myc 1A). That the predicted Mxi-SR protein indeed represents oncogenic potential, including the Max-associated pro- the mouse homolog of human MXll (Zervos et al., 1993; teins MAD and MXll (Lahoz et al., 1994), dominant nega- the human MXl clone was shown to be equivalent to mouse tive mutants of Myc (Mukherjee et al., 1992; Sawyers et al., mxi-SR and not mouse mxi-WR) is supported by their 1992), retinoblastoma (Rb), and other cell cycle regulators shared amino acid identity of 96% compared with only (Serrano et al., 1995). The functional impact of such modu- 61% when aligned with human MAD (Ayer et al., 1993). lators correlates well with their biochemical profiles and The second mxil cDNA clone, tmxi-WR, is identical to postulated mechanisms of action. For instance, Rb, which tmxi-SR in the nucleic acid sequences encoding residues is thought to interact poorly with Myc in vivo, has a minimal 37-228 of the tmxi-SR ORF and in its 3' untranslated re- suppressive effect on myclRAS-induced foci formation gion (3'UTR). However, the 5'-most sequences of the tmxi- (E. G. Lahoz and R. A. D., unpublished data), while overex- SR ORF are absent from tmxi-WR and are replaced by pression of MAD or MXl leads to a profound reduction different sequences that do not encode an in-frame ORF. in transformation activity in a highly Myc-specific manner As a result, the putative protein encoded by tmxi-WR (Lahoz et al., 1994). would likely initiate translation at an ATG that corresponds In the course of investigating the basis of the anti- to a methionine at position 37 in the Mxi-SR protein (Mxi- oncogenic activity of Mxil, we identified two mxil mRNAs WR in Figure 1A). that arise through alternative RNA processing and that The Mxi.SR Amino.Terminal Extension encode proteins with dramatically different abilities to re- While mxi-SR and mxi-WR ORFs encode identical bHLH- press myc-induced transformation. The capacity for strong LZ and carboxy-terminal regions, alternative utilization of repressive activity correlates with an amino-terminal ex- 5' sequences extends the mxil-SR ORF an additional 36 tension of 36 residues that is present in only one of the amino acids beyond the mxil-WR ORF. This extension is two Mxi protein forms. Significantly, use of the yeast two- highly conserved throughout vertebrate evolution, exhib- hybrid interaction system showed that this highly con- iting 100% similaritywith human MXI 1 (Zervos et al., 1993) served (z-helical "repression" domain of Mxil (and MAD) and 72% similarity with zebra fish Mxil (Schreiber-Agus associates with a murine homolog of the yeast transcrip- et al., 1994) (Figure 1B; zebra fish not shown). Notably, tional repressor SIN3 (Nasmyth et al., 1987; Sternberg et this region is also highly homologous (78% similar) to an al., 1987; Strich et al., 1989; Wang et al., 1990; Vidal et analogously positioned domain in human MAD (Ayer et al., al., 1991; Wang and Stillman, 1993). Through coimmuno- 1993) (Figure 1 B). The secondary structure of this Mxil-SR precipitation studies in mammalian cells, Mxil and mouse amino-terminal extension is predicted to be strongly (z-heli- Sin3 (roSin3) were shown to be part of a ternary complex cal, and the potential for (~ helicity is conserved in the human that also included Max.
Recommended publications
  • MYCL Promotes Ipsc-Like Colony Formation Via MYC Box 0 and 2 Domains
    MYCL promotes iPSC-like colony formation via MYC Box 0 and 2 domains Chiaki Akifuji Department of Life Science Frontiers, Center for iPS cell Research and Application (CiRA), Kyoto University Mio Iwasaki Department of Life Science Frontiers, Center for iPS cell Research and Application (CiRA), Kyoto University Yuka Kawahara Department of Life Science Frontiers, Center for iPS cell Research and Application (CiRA), Kyoto University Chiho Sakurai Department of Life Science Frontiers, Center for iPS cell Research and Application (CiRA), Kyoto University Yusheng Cheng Department of Life Science Frontiers, Center for iPS cell Research and Application (CiRA), Kyoto University Takahiko Imai Department of Life Science Frontiers, Center for iPS cell Research and Application (CiRA), Kyoto University Masato Nakagawa ( [email protected] ) Department of Life Science Frontiers, Center for iPS cell Research and Application (CiRA), Kyoto University Research Article Keywords: mycl, reprogramming, ipsc, eciency, induced Posted Date: August 19th, 2021 DOI: https://doi.org/10.21203/rs.3.rs-817686/v1 License: This work is licensed under a Creative Commons Attribution 4.0 International License. Read Full License 1 MYCL promotes iPSC-like colony formation via MYC Box 0 and 2 domains 2 3 Authors 4 Chiaki Akifuji1, Mio Iwasaki1, Yuka Kawahara1, Chiho Sakurai1, Yusheng Cheng1, Takahiko 5 Imai1, and Masato Nakagawa1* 6 7 Affiliation 8 1 Department of Life Science Frontiers, Center for iPS cell Research and Application (CiRA), 9 Kyoto University, Kyoto 606-8507, Japan 10 11 *Correspondence: [email protected] 12 13 Abstract 14 Induced pluripotent stem cells (iPSCs) have the potential to differentiate into any cell in 15 the body and thus have attractive regenerative medicine potential.
    [Show full text]
  • Figure S1. Representative Report Generated by the Ion Torrent System Server for Each of the KCC71 Panel Analysis and Pcafusion Analysis
    Figure S1. Representative report generated by the Ion Torrent system server for each of the KCC71 panel analysis and PCaFusion analysis. (A) Details of the run summary report followed by the alignment summary report for the KCC71 panel analysis sequencing. (B) Details of the run summary report for the PCaFusion panel analysis. A Figure S1. Continued. Representative report generated by the Ion Torrent system server for each of the KCC71 panel analysis and PCaFusion analysis. (A) Details of the run summary report followed by the alignment summary report for the KCC71 panel analysis sequencing. (B) Details of the run summary report for the PCaFusion panel analysis. B Figure S2. Comparative analysis of the variant frequency found by the KCC71 panel and calculated from publicly available cBioPortal datasets. For each of the 71 genes in the KCC71 panel, the frequency of variants was calculated as the variant number found in the examined cases. Datasets marked with different colors and sample numbers of prostate cancer are presented in the upper right. *Significantly high in the present study. Figure S3. Seven subnetworks extracted from each of seven public prostate cancer gene networks in TCNG (Table SVI). Blue dots represent genes that include initial seed genes (parent nodes), and parent‑child and child‑grandchild genes in the network. Graphical representation of node‑to‑node associations and subnetwork structures that differed among and were unique to each of the seven subnetworks. TCNG, The Cancer Network Galaxy. Figure S4. REVIGO tree map showing the predicted biological processes of prostate cancer in the Japanese. Each rectangle represents a biological function in terms of a Gene Ontology (GO) term, with the size adjusted to represent the P‑value of the GO term in the underlying GO term database.
    [Show full text]
  • Transcriptional Control of Tissue-Resident Memory T Cell Generation
    Transcriptional control of tissue-resident memory T cell generation Filip Cvetkovski Submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy in the Graduate School of Arts and Sciences COLUMBIA UNIVERSITY 2019 © 2019 Filip Cvetkovski All rights reserved ABSTRACT Transcriptional control of tissue-resident memory T cell generation Filip Cvetkovski Tissue-resident memory T cells (TRM) are a non-circulating subset of memory that are maintained at sites of pathogen entry and mediate optimal protection against reinfection. Lung TRM can be generated in response to respiratory infection or vaccination, however, the molecular pathways involved in CD4+TRM establishment have not been defined. Here, we performed transcriptional profiling of influenza-specific lung CD4+TRM following influenza infection to identify pathways implicated in CD4+TRM generation and homeostasis. Lung CD4+TRM displayed a unique transcriptional profile distinct from spleen memory, including up-regulation of a gene network induced by the transcription factor IRF4, a known regulator of effector T cell differentiation. In addition, the gene expression profile of lung CD4+TRM was enriched in gene sets previously described in tissue-resident regulatory T cells. Up-regulation of immunomodulatory molecules such as CTLA-4, PD-1, and ICOS, suggested a potential regulatory role for CD4+TRM in tissues. Using loss-of-function genetic experiments in mice, we demonstrate that IRF4 is required for the generation of lung-localized pathogen-specific effector CD4+T cells during acute influenza infection. Influenza-specific IRF4−/− T cells failed to fully express CD44, and maintained high levels of CD62L compared to wild type, suggesting a defect in complete differentiation into lung-tropic effector T cells.
    [Show full text]
  • Original Article MYCN-Mediated Regulation of the HES1 Promoter Enhances the Chemoresistance of Small-Cell Lung Cancer by Modulating Apoptosis
    Am J Cancer Res 2019;9(9):1938-1956 www.ajcr.us /ISSN:2156-6976/ajcr0100301 Original Article MYCN-mediated regulation of the HES1 promoter enhances the chemoresistance of small-cell lung cancer by modulating apoptosis Qin Tong1,2*, Shuming Ouyang3*, Rui Chen1, Jie Huang4, Linlang Guo1 1Department of Pathology, Zhujiang Hospital, Southern Medical University, 253 Gongye Road, Guangzhou 510282, People’s Republic of China; Departments of 2Radiation Oncology, 3Reproductive Medicine, The First Affiliated Hospital of University of South China, Hengyang 421001, People’s Republic of China; 4Guangdong Lung Cancer Institute, Guangdong Provincial Key Laboratory of Translational Medicine in Lung Cancer, Guangdong Provincial People’s Hospital & Guangdong Academy of Medical Sciences, Guangzhou 510080, People’s Republic of China. *Equal contributors. Received June 29, 2019; Accepted August 10, 2019; Epub September 1, 2019; Published September 15, 2019 Abstract: MYCN, a member of the MYC family, is correlated with tumorigenesis, metastasis and therapy in many malig nancies; however, its role in small-cell lung cancer (SCLC) remains unclear. In this study, we sought to identify the function of MYCN in SCLC chemoresistance and found that MYCN is overexpressed in chemoresistant SCLC cells. We used MYCN gain- and loss-of- function experiments to demonstrate that MYCN promotes in vitro and in vivo chemoresistance in SCLC by inhibiting apoptosis. Mechanistic investigations showed that MYCN binds to the HES1 promoter and exhibits transcriptional activity. Furthermore, MYCN mediated SCLC chemoresistance through HES1. Accordingly, the NOTCH inhibitor FLI-60 derepressed HES1 and diminished MYCN-induced chemoresistance in SCLC. Finally, the positive correlation between HES1 and MYCN was confirmed in SCLC patients.
    [Show full text]
  • Supplementary Table S4. FGA Co-Expressed Gene List in LUAD
    Supplementary Table S4. FGA co-expressed gene list in LUAD tumors Symbol R Locus Description FGG 0.919 4q28 fibrinogen gamma chain FGL1 0.635 8p22 fibrinogen-like 1 SLC7A2 0.536 8p22 solute carrier family 7 (cationic amino acid transporter, y+ system), member 2 DUSP4 0.521 8p12-p11 dual specificity phosphatase 4 HAL 0.51 12q22-q24.1histidine ammonia-lyase PDE4D 0.499 5q12 phosphodiesterase 4D, cAMP-specific FURIN 0.497 15q26.1 furin (paired basic amino acid cleaving enzyme) CPS1 0.49 2q35 carbamoyl-phosphate synthase 1, mitochondrial TESC 0.478 12q24.22 tescalcin INHA 0.465 2q35 inhibin, alpha S100P 0.461 4p16 S100 calcium binding protein P VPS37A 0.447 8p22 vacuolar protein sorting 37 homolog A (S. cerevisiae) SLC16A14 0.447 2q36.3 solute carrier family 16, member 14 PPARGC1A 0.443 4p15.1 peroxisome proliferator-activated receptor gamma, coactivator 1 alpha SIK1 0.435 21q22.3 salt-inducible kinase 1 IRS2 0.434 13q34 insulin receptor substrate 2 RND1 0.433 12q12 Rho family GTPase 1 HGD 0.433 3q13.33 homogentisate 1,2-dioxygenase PTP4A1 0.432 6q12 protein tyrosine phosphatase type IVA, member 1 C8orf4 0.428 8p11.2 chromosome 8 open reading frame 4 DDC 0.427 7p12.2 dopa decarboxylase (aromatic L-amino acid decarboxylase) TACC2 0.427 10q26 transforming, acidic coiled-coil containing protein 2 MUC13 0.422 3q21.2 mucin 13, cell surface associated C5 0.412 9q33-q34 complement component 5 NR4A2 0.412 2q22-q23 nuclear receptor subfamily 4, group A, member 2 EYS 0.411 6q12 eyes shut homolog (Drosophila) GPX2 0.406 14q24.1 glutathione peroxidase
    [Show full text]
  • 1714 Gene Comprehensive Cancer Panel Enriched for Clinically Actionable Genes with Additional Biologically Relevant Genes 400-500X Average Coverage on Tumor
    xO GENE PANEL 1714 gene comprehensive cancer panel enriched for clinically actionable genes with additional biologically relevant genes 400-500x average coverage on tumor Genes A-C Genes D-F Genes G-I Genes J-L AATK ATAD2B BTG1 CDH7 CREM DACH1 EPHA1 FES G6PC3 HGF IL18RAP JADE1 LMO1 ABCA1 ATF1 BTG2 CDK1 CRHR1 DACH2 EPHA2 FEV G6PD HIF1A IL1R1 JAK1 LMO2 ABCB1 ATM BTG3 CDK10 CRK DAXX EPHA3 FGF1 GAB1 HIF1AN IL1R2 JAK2 LMO7 ABCB11 ATR BTK CDK11A CRKL DBH EPHA4 FGF10 GAB2 HIST1H1E IL1RAP JAK3 LMTK2 ABCB4 ATRX BTRC CDK11B CRLF2 DCC EPHA5 FGF11 GABPA HIST1H3B IL20RA JARID2 LMTK3 ABCC1 AURKA BUB1 CDK12 CRTC1 DCUN1D1 EPHA6 FGF12 GALNT12 HIST1H4E IL20RB JAZF1 LPHN2 ABCC2 AURKB BUB1B CDK13 CRTC2 DCUN1D2 EPHA7 FGF13 GATA1 HLA-A IL21R JMJD1C LPHN3 ABCG1 AURKC BUB3 CDK14 CRTC3 DDB2 EPHA8 FGF14 GATA2 HLA-B IL22RA1 JMJD4 LPP ABCG2 AXIN1 C11orf30 CDK15 CSF1 DDIT3 EPHB1 FGF16 GATA3 HLF IL22RA2 JMJD6 LRP1B ABI1 AXIN2 CACNA1C CDK16 CSF1R DDR1 EPHB2 FGF17 GATA5 HLTF IL23R JMJD7 LRP5 ABL1 AXL CACNA1S CDK17 CSF2RA DDR2 EPHB3 FGF18 GATA6 HMGA1 IL2RA JMJD8 LRP6 ABL2 B2M CACNB2 CDK18 CSF2RB DDX3X EPHB4 FGF19 GDNF HMGA2 IL2RB JUN LRRK2 ACE BABAM1 CADM2 CDK19 CSF3R DDX5 EPHB6 FGF2 GFI1 HMGCR IL2RG JUNB LSM1 ACSL6 BACH1 CALR CDK2 CSK DDX6 EPOR FGF20 GFI1B HNF1A IL3 JUND LTK ACTA2 BACH2 CAMTA1 CDK20 CSNK1D DEK ERBB2 FGF21 GFRA4 HNF1B IL3RA JUP LYL1 ACTC1 BAG4 CAPRIN2 CDK3 CSNK1E DHFR ERBB3 FGF22 GGCX HNRNPA3 IL4R KAT2A LYN ACVR1 BAI3 CARD10 CDK4 CTCF DHH ERBB4 FGF23 GHR HOXA10 IL5RA KAT2B LZTR1 ACVR1B BAP1 CARD11 CDK5 CTCFL DIAPH1 ERCC1 FGF3 GID4 HOXA11 IL6R KAT5 ACVR2A
    [Show full text]
  • The Id-Protein Family in Developmental and Cancer-Associated Pathways Cornelia Roschger and Chiara Cabrele*
    Roschger and Cabrele Cell Communication and Signaling (2017) 15:7 DOI 10.1186/s12964-016-0161-y REVIEW Open Access The Id-protein family in developmental and cancer-associated pathways Cornelia Roschger and Chiara Cabrele* Abstract Inhibitors of DNA binding and cell differentiation (Id) proteins are members of the large family of the helix-loop- helix (HLH) transcription factors, but they lack any DNA-binding motif. During development, the Id proteins play a key role in the regulation of cell-cycle progression and cell differentiation by modulating different cell-cycle regulators both by direct and indirect mechanisms. Several Id-protein interacting partners have been identified thus far, which belong to structurally and functionally unrelated families, including, among others, the class I and II bHLH transcription factors, the retinoblastoma protein and related pocket proteins, the paired-box transcription factors, and the S5a subunit of the 26 S proteasome. Although the HLH domain of the Id proteins is involved in most of their protein-protein interaction events, additional motifs located in their N-terminal and C-terminal regions are required for the recognition of diverse protein partners. The ability of the Id proteins to interact with structurally different proteins is likely to arise from their conformational flexibility: indeed, these proteins contain intrinsically disordered regions that, in the case of the HLH region, undergo folding upon self- or heteroassociation. Besides their crucial role for cell-fate determination and cell-cycle progression during development, other important cellular events have been related to the Id-protein expression in a number of pathologies. Dysregulated Id-protein expression has been associated with tumor growth, vascularization, invasiveness, metastasis, chemoresistance and stemness, as well as with various developmental defects and diseases.
    [Show full text]
  • Targeting MYC-Induced Metabolic Reprogramming and Oncogenic Stress in Cancer
    Author Manuscript Published OnlineFirst on July 29, 2013; DOI: 10.1158/1078-0432.CCR-12-3629 Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited. Molecular Pathways: Targeting MYC-induced Metabolic Reprogramming and Oncogenic Stress in Cancer Bo Li and M. Celeste Simon Authors’ affiliation: Abramson Family Cancer Research Institute, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania; Howard Hughes Medical Institute, Philadelphia, Pennsylvania Corresponding author: M. Celeste Simon, 456 BRB II/III, Abramson Family Cancer Research Institute, Perelman School of Medicine at the University of Pennsylvania, 421 Curie Blvd., Philadelphia, PA 19104. Phone: 215-746-5532; Fax: 215-746-5511; Email: [email protected] Grant support: The authors’ laboratory is supported by the Howard Hughes Medical Institute and by NIH Grant CA104838 (to M.C. Simon). M.C. Simon is an Investigator of the Howard Hughes Medical Institute. The authors have no conflicts of interest. Abstract MYC is a multi-functional transcription factor that is deregulated in many human cancers. MYC impacts a collaborative genetic program that orchestrates cell proliferation, metabolism, and stress responses. Although the progression of MYC-amplified tumors shows robust dependence on MYC activity, directly targeting MYC as a therapeutic method has proven to be technically difficult. Therefore, alternative approaches are currently under development with a focus on interference with MYC-mediated downstream effects. To fuel rapid cell growth, MYC reprograms cancer cell metabolism in a way that is substantially different from normal cells. The MYC-induced metabolic signature is characterized by enhanced glucose and glutamine uptake, increased lactate production, and altered amino acid metabolism.
    [Show full text]
  • Transcriptome Analysis of the Uterus of Hens Laying Eggs Differing in Cuticle Deposition Sandra Poyatos Pertiñez1* , Peter W
    Poyatos Pertiñez et al. BMC Genomics (2020) 21:516 https://doi.org/10.1186/s12864-020-06882-7 RESEARCH ARTICLE Open Access Transcriptome analysis of the uterus of hens laying eggs differing in cuticle deposition Sandra Poyatos Pertiñez1* , Peter W. Wilson1, Wiebke Icken2, David Cavero3, Maureen M. Bain4, Anita C. Jones5 and Ian C. Dunn1 Abstract Background: Avian eggs have a proteinaceous cuticle. The quantity of cuticle varies and the deposition of a good cuticle in the uterus (Shell-gland) prevents transmission of bacteria to the egg contents. Results: To understand cuticle deposition, uterus transcriptomes were compared between hens with i) naturally good and poor cuticle and, ii) where manipulation of the hypothalamo-pituitary-gonadal-oviduct axis produced eggs with or without cuticle. The highest expressed genes encoded eggshell matrix and cuticle proteins, e.g. MEPE (OC-116), BPIFB3 (OVX-36), RARRES1 (OVX-32), WAP (OVX-25), and genes for mitochondrial oxidative phosphorylation, active transport and energy metabolism. Expression of a number of these genes differed between hens laying eggs with or without cuticle. There was also a high expression of clock genes. PER2, CRY2, CRY1, CLOCK and BMAL1 were differentially expressed when cuticle deposition was prevented, and they also changed throughout the egg formation cycle. This suggests an endogenous clock in the uterus may be a component of cuticle deposition control. Cuticle proteins are glycosylated and glycosaminoglycan binding genes had a lower expression when cuticle proteins were deposited on the egg. The immediate early genes, JUN and FOS, were expressed less when the cuticle had not been deposited and changed over the egg formation cycle, suggesting they are important in oviposition and cuticle deposition.
    [Show full text]
  • Lineage Transcription Factors Co-Regulate Subtype-Specific Genes Providing a Roadmap For
    bioRxiv preprint doi: https://doi.org/10.1101/2020.08.13.249029; this version posted August 14, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. Lineage transcription factors co-regulate subtype-specific genes providing a roadmap for systematic identification of small cell lung cancer vulnerabilities Karine Pozo1,2, Rahul K. Kollipara3, Demetra P. Kelenis1, Kathia E. Rodarte1, Xiaoyang Zhang4, John D. Minna5,6,7,8 and Jane E. Johnson1,6,8 1Department of Neuroscience, 2Department of Surgery, 3McDermott Center for Human Growth and Development, UT Southwestern Medical Center, Dallas, TX 75390, USA 4Department of Oncological Sciences, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT 5Hamon Center for Therapeutic Oncology Research, 6Simmons Comprehensive Cancer Center, 7Department of Internal Medicine, 8Department of Pharmacology, UT Southwestern Medical Center, Dallas, TX 75390, USA JDM receives licensing fees for lung cancer lines from the NIH and UT Southwestern. 1 bioRxiv preprint doi: https://doi.org/10.1101/2020.08.13.249029; this version posted August 14, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. ABSTRACT Lineage-defining transcription factors (LTFs) play key roles in tumor cell growth, making them highly attractive, but currently “undruggable”, small cell lung cancer (SCLC) vulnerabilities.
    [Show full text]
  • Hypoxia and Aging Eui-Ju Yeo1
    Yeo Experimental & Molecular Medicine (2019) 51:67 https://doi.org/10.1038/s12276-019-0233-3 Experimental & Molecular Medicine REVIEW ARTICLE Open Access Hypoxia and aging Eui-Ju Yeo1 Abstract Eukaryotic cells require sufficient oxygen (O2) for biological activity and survival. When the oxygen demand exceeds its supply, the oxygen levels in local tissues or the whole body decrease (termed hypoxia), leading to a metabolic crisis, threatening physiological functions and viability. Therefore, eukaryotes have developed an efficient and rapid oxygen sensing system: hypoxia-inducible factors (HIFs). The hypoxic responses are controlled by HIFs, which induce the expression of several adaptive genes to increase the oxygen supply and support anaerobic ATP generation in eukaryotic cells. Hypoxia also contributes to a functional decline during the aging process. In this review, we focus on the molecular mechanisms regulating HIF-1α and aging-associated signaling proteins, such as sirtuins, AMP-activated protein kinase, mechanistic target of rapamycin complex 1, UNC-51-like kinase 1, and nuclear factor κB, and their roles in aging and aging-related diseases. In addition, the effects of prenatal hypoxia and obstructive sleep apnea (OSA)- induced intermittent hypoxia have been reviewed due to their involvement in the progression and severity of many diseases, including cancer and other aging-related diseases. The pathophysiological consequences and clinical manifestations of prenatal hypoxia and OSA-induced chronic intermittent hypoxia are discussed in detail. Introduction chemoreceptors stimulates the neurotransmitter release 3 1234567890():,; 1234567890():,; 1234567890():,; 1234567890():,; Oxygen (O2) plays critical roles in aerobic respiration pathway and modulates the activity of a neutral endo- and metabolism as the final electron acceptor of the peptidase, neprilysin (NEP), which modifies the cellular mitochondrial electron transport chain, which is respon- response to hypoxia by hydrolyzing substance P4.
    [Show full text]
  • 1.1.4.1. Tumour Suppressor Genes
    To my Mother and Father Learn from yesterday, live for today, hope for tomorrow. The important thing is not to stop questioning. Albert Einstein Inhibition of Tumourigenicity of Small Cell Lung Cancer by Simultaneous Suppression of Id1 and Id3 Expression Danqing Chen ABSTRACT Inhibitor of DNA binding (Id) proteins are a group of transcription factors belonging to the basic helix-loop-helix (bHLH) family and play a wide range of roles in differentiation, proliferation and cell cycle progression. Id proteins act as negative dominant regulators of other bHLH factors by making dimers to these factors to prevent them from binding to E-box of DNA and, hence, to inhibit transcription of target genes. In this work, we first established SCLC cell line N417-derived sublines expressing reduced levels of Id1 and Id3 by transfection of a single vector constructed to co-express two shRNAs simultaneously. Then we investigated the effect of either singly or jointly suppressed Id1 or Id3 on tumourigenicity of SCLC cells in vitro and in vivo. The molecular mechanisms involved in the functional roles of Id1 and Id3 were also assessed. Id1-suppressed cells and Id1 and Id3 double knockdown cells produced significant reductions in proliferation rate by more than 1.4- and 3.9-fold respectively when compared with the control. Soft agar assay showed the number of colonies produced by Id1-suppressed cells and Id1 and Id3 double knockdown cells were reduced by more than 13.7- and 233-fold respectively compared with the control. The suppression effect was also observed in the invasion assay which showed that Id1-suppressed cells and Id1 and Id3 double knockdown cells produced more than 1.7- and 4.6- fold reduction respectively in relative invasiveness.
    [Show full text]